---
category: news
title: "Late-Breaking New Independent Validation Study of 1,674 Patients Demonstrates Castle Biosciences' i31-GEP Artificial Intelligence Algorithm Improves Precision of Sentinel Lymph ..."
excerpt: "Castle presented new data on the integration of the DecisionDxÂ®-Melanoma test with clinicopathologic features (i31-GEP)."
publishedDateTime: 2021-04-15T11:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20210415005322/en/Late-Breaking-New-Independent-Validation-Study-of-1674-Patients-Demonstrates-Castle-Biosciences-i31-GEP-Artificial-Intelligence-Algorithm-Improves-Precision-of-Sentinel-Lymph-Node-Positivity-Prediction-in-Cutaneous-Melanoma"
webUrl: "https://www.businesswire.com/news/home/20210415005322/en/Late-Breaking-New-Independent-Validation-Study-of-1674-Patients-Demonstrates-Castle-Biosciences-i31-GEP-Artificial-Intelligence-Algorithm-Improves-Precision-of-Sentinel-Lymph-Node-Positivity-Prediction-in-Cutaneous-Melanoma"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - Machine Learning
  - AI

secured: "4WybPfb1hamou9V17VM9521dp5xwUaPCjY8lbvRNzLG82LUXNla5MplofBLf+lPbt3MRos4wkakiVLwjnn24dAjPUt/HYWO9yvOu8yOIKXduavhpfMnKvmMcbjwtJUncA+MGNWhja/f00j9aRl+lotaZSCkwJM49AWVlMgC5N0Htv4qMivXZ8p+JahOZx+DYIVLvvwuU6pNRTX5OriktvvW+ihBdp8TehX3gvR3UF+Mgx0c+DbpIG41ZqvINGaS3gWauC4aLkbJL1eJy3lTKjNrCntfrFZZFPUgndN/h9nvphxvfm7+DB7Km1bXqb/0HAs9XxbQkY3XY5JDRUAag3jYR1T4ewrZhJPydjjXgzGA=;5D6SvLhIadcUj0yhPb/PIw=="
---

